| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Year to date, Thermo Fisher fell about 21.03%, both underperforming the iShares U.S. Healthcare ETF, which declined about 2.36%.
Shares of companies within the broader financials sector are trading lower as markets reacted to Trump's sweeping tariff an...
Alaska Air Group reports Q4 sales of $3.53B, surpassing street view, aided by strong leisure demand and rebound in corporate tr...
Analyst predicts positive Q3 earnings for Hewlett Packard due to demand for AI, infrastructure recovery, equipment demand, and ...
Toll Brothers CEO expects robust demand for luxury homes through 2025 after solid results, with strong demand in CA, NJ, PA, SC...
Piper analyst raised EPS estimates for IBKR after stronger-than-expected Q2 results. Management expects continued account growt...